Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest tumor Stories

2013-11-14 08:33:06

Findings further demonstrate the validity of a multiple-technology approach to tumor profiling for cancer patients IRVING, Texas, Nov. 14, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present five tumor profiling studies at the 2013 Annual Meeting of the Association for Molecular Pathology (AMP), held this week in Phoenix, Ariz. Results were obtained using Caris' comprehensive tumor profiling...

2013-11-11 04:21:07

-Study Features THC and CBD as the Primary Cannabinoids- LONDON, Nov. 11, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme (GBM). Glioma describes any tumor that arises from the glial tissue...

2013-11-09 23:03:29

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends 18-year-old Dominique Cooks for his perseverance in following his dreams despite brain cancer diagnosis. New York, NY (PRWEB) November 09, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Dominique Cooks, an 18-year-old brain cancer patient, for his perseverance and will to follow his dreams despite his diagnosis. According to an...

New Driver Of Breast Cancer Discovered
2013-11-07 12:35:45

UT Southwestern Medical Center A team of researchers at UT Southwestern has found that as cholesterol is metabolized, a potent stimulant of breast cancer is created – one that fuels estrogen-receptor positive breast cancers, and that may also defeat a common treatment strategy for those cancers. The multidisciplinary team discovered that a cholesterol metabolite called 27-hydroxycholesterol, or 27HC, promotes tumor growth in estrogen-receptor positive breast cancers, which are the...

2013-11-07 12:28:07

TSX Venture: QPT EDMONTON, Nov. 7, 2013 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, announces the presentation of a late-breaking abstract at the 28(th) Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on November 9, 2013 in Maryland, U.S. The work was jointly developed by Stanford University, AIT Strategies and Quest as continuation of...

2013-11-06 11:17:55

Coordinated overactivation of TGFb and CXCR4 signaling pathways confer migratory properties to the hepatocellular carcinoma cells The findings will help to identify which patients benefit TGFb inhibitory therapy. Researchers from the Biological clues of the invasive and metastatic phenotype group of the Bellvitge Biomedical Research Institute (IDIBELL) led by Isabel Fabregat have discovered the relationship between the TGFb signalling pathways and CXCR4 in hepatocellular carcinoma (HCC)...

2013-11-05 10:55:56

Study confirms that vascular normalization is the way these drugs improve patient survival Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, Massachusetts General Hospital (MGH) researchers report, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their...

2013-11-05 10:46:44

New technique may also have application in genomics to identify genes that influence risk of disease Researchers at the University of Chicago are developing computer-aided diagnosis (CADx) and quantitative image analysis (QIA) methods for mammograms, ultrasounds and magnetic resonance images (MRIs) to identify specific tumor characteristics, including size, shape and sharpness, said lead researcher Maryellen Giger, A.N. Pritzker Professor of Radiology/Medical Physics and director of the...

2013-11-05 08:36:35

The NovoTAL System Enables Certified Physicians to Plan and Individualize NovoTTF(TM) Therapy for Recurrent Glioblastoma Patients NEW YORK, Nov. 5, 2013 /PRNewswire/ -- Novocure announced today that the United States Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) System through a Premarket Approval (PMA) supplement. The NovoTAL System allows certified physicians to use the individual MRI data of recurrent glioblastoma multiforme (GBM) patients...

2013-11-01 08:26:52

Novel hydrogel acts as drug delivery depot that reduces tumor size in fewer treatments than traditional therapies SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ -- Today, scientists from IBM (NYSE: IBM) and Singapore's Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver treatment more efficiently to people fighting breast cancer. (Logo:...